News
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
January 04, 2022- Company Also Announces Move to an Expanded Scientific and Business Facility in Israel
- December 03, 2021- Dr. Weiner Brings Chemomab Extensive Biotechnology and Pharmaceutical Industry R&D and Strategic Experience, Including Overseeing the Design and Management of Clinical Trials for Rare and Challenging Therapeutic Indications
- December 02, 2021--First U.S. IND Enables Increase in the Number of Clinical Sites for Chemomab's Ongoing Phase 2 SPRING Trial--
- Chemomab Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate UpdateNovember 12, 2021Expands Senior Management Team While Advancing Two Independent Phase 2 Trials and Preparing to Initiate a Third in Early 2022
- November 10, 2021--New Preclinical Data Further Supports Ability of CM-101 to Break the Vicious Cycle of Inflammation and Fibrosis in Primary Sclerosing Cholangitis--
November 08, 2021Seasoned veteran brings Chemomab three decades of diverse life sciences industry experience- October 26, 2021Live Event featuring Dr. Dinesh Khanna to be Held Wednesday, November 3rd from 10:00 am - 11:00 am ET